Epidemiological, Clinical Progress Aspects of Congenital Heart Disease with Neonatal Revelation at the Mother-Child Hospital of Bingerville (HME) Concerning 98 Cases from January 2021 to December 2022 (Côte d’Ivoire)
Introduction？The distribution of congenital
heart disease (CHD) in sub-Saharan Africa is highly imprecise and varies from
one region to another due to the inequality of diagnostic facilities. The aim
of this study was to determine the in-hospital prevalence of congenital heart
disease in children at the Mother-Child hospital of Bingerville (HME) by
specifying the diagnostic, therapeutic and evolutionary aspects. Materials
and methods We conducted a retrospective, descriptive, cross-sectional
study at HME of Bingerville from January 2021 to December 2022. All newborns
with congenital heart disease confirmed by echocardiography were included in
the study. Results Of 656 admissions to the neonatology department over
the study period, congenital heart disease accounted for 14.9% (98/656) of
cases. In our series, 76.7% were diagnosed before the 1st week of life, with a
mean chronological age of 5.18 days and extremes of 0 and 46 days. There were
as many male patients (50%) as female (50%), i.e. a sex ratio of 1. These newborns were premature in 60.2% of
cases, with a mean and median gestational age of 34 weeks’ amenorrhea. Most
were left-right shunts (90.8%). Persistent ductus arteriosus (PDA) (48.9%)
predominated, followed by atrial septal defect (38.7%), ventricular septal
defect (13.3%), common trunk artery (CTA) (3.1%) and open septal pulmonary
atresia (OSPA) (1%) as the primary cyanogenic heart disease. Pulmonary arterial
hypertension (PAH) (50%) was primary in 38.8% and secondary (61.2%). The
mortality rate was 30.6%, and all CTA patients died (100%), with a significant
statistical relationship (p = 0.027). Progression under treatment was marked by
clinical stabilization (68/98) in 69.4% of cases. Conclusion: Congenital
heart disease is relatively common at the Bingerville HME. Access to
echocardiography should be facilitated in neonatology departments for rapid
diagnosis and optimal
References
[1]
Robert-Gnansia, E., Francannet, C., Bozio, A. and Bouvagnet, P. (2004) épidémiologie, étiologie et génétique des cardiopathies congénitales, EMC—Cardiologie-Angéiologie, 1, 140-160.
https://doi.org/10.1016/j.emcaa.2004.02.002
[2]
WHO Reveals Leading Causes of Death and Disability Worldwide: 2000-2019.
https://www.who.int/fr/news/item/09-12-2020-who-reveals-leading-causes-of-death-and-disability-worldwide-2000-2019
[3]
Iselin, M. (1999) Cardiopathies congénitales. Encycl Méd Chir (Elsevier, Paris), Radiodiagnostic-Cœur-Poumon 32-015-A-12, 7 p.
[4]
Mocumbi, A.O., Lameira, E., Yaksh, A., et al. (2011) Challenges on the Management of Congenital Heart Disease in Developing Countries. International Journal of Cardiology, 148, 285-288. https://doi.org/10.1016/j.ijcard.2009.11.006
[5]
Yangni-Angate, K.H., Meneas, C., Diby, F., Diomande, M., Adoubi, A. and Tanauh, Y. (2016) Cardiac Surgery in Africa: A Thirty-Five-Year Experience on Open Heart Surgery in Cote d’Ivoire. Cardiovascular Diagnosis and Therapy, 6, S44-S63.
https://doi.org/10.21037/cdt.2016.10.06
[6]
Azagoh-Kouadio, R., Diby, K.F., Asse, K.V., Gnaba, L., Aka-Tanoh, K.A., Yeboua, K.R., Yao, K.C., Avi, C. and Oulai, S. (2018) Childhood Heart Disease in Cote d’Ivoire: Retrospective Multicentric Study about 228 Cases. Open Journal of Pediatrics, 8, 375-388. https://doi.org/10.4236/ojped.2018.84037
[7]
Kinda, G., Millogo, G.R., Koueta, F., Dao, L., Talboussouma, S., Cissé, H., Djiguimdé, A., Yé, D. and Sorgho, L.C. (2015) Cardiopathies congénitales: Aspects épidémiologiques et échographiques à propos de 109 cas au centre hospitalier et universitaires pédiatrique Charles de Gaulle (CHUP-CDG) de Ouagadougou, Burkina Faso. Pan African Medical Journal, 20, Article No. 81.
[8]
Sainz, J.A., Zurita, M.J., Guillen, I., Borrero, C., García-Mejido, J., Almeida, C., Turmo, E. and Garrido, R. (2015) Cribado prenatal de cardiopatías congénitas en población de bajo riesgo de defectos congénitos. Una realidad en la actualidad [Prenatal Screening of Congenital Heart Defects in Population at Low Risk of Congenital Defects. A Reality Today]. Anales de Pediatría (Barc), 82, 27-34.
https://doi.org/10.1016/j.anpedi.2013.10.039
[9]
Cao, Y., Huang, R., Kong, R., Li, H., Zhang, H., Li, Y., Liang, L., et al. (2022) Prevalence and Risk Factors for Congenital Heart Defects among Children in the Multi-Ethnic Yunnan Region of China. Translational Pediatrics, 11, 813-824.
https://doi.org/10.21037/tp-21-371
[10]
Niakara, A., Ouédraogo, B.J., Ouédraogo, N., et al. (1999) Apport et limite de l’échographie trans-thoracique sans Doppler dans l’évaluation des cardiopathies: à propos de mille examens réalisés à Ouagadougou. Burkina Medical, 2, 53-59.
[11]
Nezami, A., Heidari, G., Tarhani, F. and Kariminia, M. (2021) Prevalence of Congenital Heart Disease among Children in Khorramabad (West of Iran). Cardiovascular & Hematological Disorders-Drug Targets, 21, 61-65.
https://doi.org/10.2174/1871529X20999201231205746
[12]
Ngouala, B.B., Aflanga, A.D., Leye, M. and Kane, A. (2015) The Prevalence of Symptomatic Infantile Heart Disease at Louga Regional Hospital, Senegal. Cardiovascular Journal of Africa, 26, e1-e5. https://doi.org/10.5830/CVJA-2015-031
[13]
Zhao, Q.M., Liu, F., Wu, L., Ma, X.J., Niu, C. and Huang, G.Y. (2019) Prevalence of Congenital Heart Disease at Live Birth in China. The Journal of Pediatrics, 204, 53-58. https://doi.org/10.1016/j.jpeds.2018.08.040
[14]
Taura, M.G., Alshahrani, A.M. and Alqahtani, D.O. (2021) Prevalence of Congenital Heart Disease among Patients with Down Syndrome in Southwestern Saudi Arabia. Annals of African Medicine, 20, 265-269.
[15]
Touti, Z., Haddour, L. and Zniber, L. (2007) Cardiopathies congénitales: Circonstances de diagnostic et classification. Revue Marocaine des maladies de l’enfant, 12, 18-25.
[16]
Jouannic, J.M. (2010) Anomalies cardiaques fœtales: Diagnostic prénatal et prise en charge périnatale. EMC Gynécologie-Obstétrique, 5, 31-38.
https://doi.org/10.1016/S0246-0335(10)52453-0
[17]
Zhang, X., Sun, Y., Zhu, J., Zhu, Y. and Qiu, L. (2020) Epidemiology, Prenatal Diagnosis, and Neonatal Outcomes of Congenital Heart Defects in Eastern China: A Hospital-Based Multicenter Study. BMC Pediatrics, 20, Article No. 416.
https://doi.org/10.1186/s12887-020-02313-4
[18]
Banou, N. (2019/2020) Profil épidémio-clinique et évolutif des cardiopathies congénitales au service de néonatalogie du CHU Gabriel Touré. Thèse.
[19]
Tanner, K., Sabrine, N. and Wren, C. (2005) Cardiovascular Malformations among Preterm Infants. Pediatrics, 116, 833-838. https://doi.org/10.1542/peds.2005-0397
[20]
Yu, G., Mao, L. and Chen, S. (2014) Clinical Features of Early Newborn Infants with Congenital Heart Disease. Chinese Journal of Cardiology, 42, 484-486.
[21]
Lee, J.S., Noh, O.K. and Park, J.E. (2023) Neonatal Risk Factors for Growth Retardation in Infants with Congenital Heart Disease. Journal of Korean Medical Science, 38, e196. https://doi.org/10.3346/jkms.2023.38.e196
[22]
Laas, E. (2012) Cardiopathies congénitales et prématurité: Une étude en population. Revue d’épidémiologie et de Santé Publique, 60, 160.
https://doi.org/10.1016/j.respe.2011.12.133
[23]
Zhang, Y., Zhang, W., Xu, H. and Liu, K. (2021) Epidemiological Aspects, Prenatal Screening and Diagnosis of Congenital Heart Defects in Beijing. Frontiers in Cardiovascular Medicine, 8, Article ID: 777899.
https://doi.org/10.3389/fcvm.2021.777899
[24]
Best, K.E. and Rankin, J. (2016) Is Advanced Maternal Age a Risk Factor for Congenital Heart Disease? Birth Defects Research. Part A, Clinical and Molecular Teratology, 106, 461-467. https://doi.org/10.1002/bdra.23507
[25]
Ekure, E.N. and Adeyemo, A.A. (2015) Clinical Epidemiology and Management of Heart Defects in a Developing Country. In: Muenke, M., Kruszka, P.S., Sable, C.A. and Belmont, J.W., Eds., Congenital Heart Disease: Molecular Genetics, Principles of Diagnosis and Treatment, Karger, Basel, 46-56.
https://doi.org/10.1159/000375204
[26]
Yuki, K. and Koutsogiannaki, S. (2021) Neutrophil and T Cell Functions in Patients with Congenital Heart Diseases: A Review. Pediatric Cardiology, 42, 1478-1482.
https://doi.org/10.1007/s00246-021-02681-3
[27]
Zhang, S., Wang, L., Yang, T., Chen, L., Zhao, L., Wang, T., Chen, L., Ye, Z., Zheng, Z. and Qin, J. (2020) Parental Alcohol Consumption and the Risk of Congenital Heart Diseases in Offspring: An Updated Systematic Review and Meta-Analysis. European Journal of Preventive Cardiology, 27, 410-421.
https://doi.org/10.1177/2047487319874530
[28]
Chou, H.H., Chiou, M.J., Liang, F.W., Chen, L.H., Lu, T.H. and Li, C.Y. (2016) Association of Maternal Chronic Disease with Risk of Congenital Heart Disease in Offspring. CMAJ, 188, E438-E446. https://doi.org/10.1503/cmaj.160061
[29]
Batisse, A., Fermont, L. and Levy, M. (2013) Cardiologie pédiatrique pratique du fœtus à l’adulte. 4e Edition, Doin, Paris, 25, 50-54, 100.
[30]
Petrossian, R.A., Kuehl, K.S. and Loffredo, C.A. (2015) Relationship of Birth Weight with Congenital Cardiovascular Malformations in a Population-Based Study. Cardiology in the Young, 25, 1086-1092. https://doi.org/10.1017/S1047951114001644
[31]
Liu, Y., Chen, S., Zühlke, L., Black, G.C., Choy, M.K., Li, N. and Keavney, B.D. (2019) Global Birth Prevalence of Congenital Heart Defects 1970-2017: Updated Systematic Review and Meta-Analysis of 260 Studies. International Journal of Epidemiology, 48, 455-463. https://doi.org/10.1093/ije/dyz009
[32]
Diller, G.P., Kempny, A., Inuzuka, R., et al. (2014) Survival Prospects of Treatment Naive Patients with Eisenmenger: A Systematic Review of the Literature and Report of Own Experience. Heart, 100, 1366-1372.
https://doi.org/10.1136/heartjnl-2014-305690
[33]
Simonneau, G., Galie, N., Rubin, L.J., et al. (2004) Clinical Classification of Pulmonary Hypertension. Journal of the American College of Cardiology, 43, S5-S12.
https://doi.org/10.1016/j.jacc.2004.02.037
